| E. COLI | Monitoring | 0 | N/A | Sep 28, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 28, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 28, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 14, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 14, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 14, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Aug 18, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Aug 18, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 20, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 20, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | May 11, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 11, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 23, 2025 | Active | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Mar 31, 2025 | Active | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Mar 31, 2025 | Active | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Mar 31, 2025 | Active | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Mar 31, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 15, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 15, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 6, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 6, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 24, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 24, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2024 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 8, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 8, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 8, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 20, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 20, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 20, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Sep 8, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 2, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 23, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 23, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 23, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 23, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 23, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 25, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 25, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 25, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | May 10, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 25, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 25, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 21, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 21, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 21, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 21, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 7, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Dec 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 16, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 17, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 17, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 17, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 17, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 17, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 17, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Oct 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 10, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 10, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 10, 2023 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 10, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 10, 2023 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2022 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 27, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 27, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 10, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 10, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 10, 2022 | Active | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 20, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 20, 2021 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 11, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 11, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |